- Northcoast Research upgraded HD Supply Holdings Inc HDS from Neutral to Buy. HD Supply shares rose 3.71 percent to $23.57 in pre-market trading.
- Guggenheim upgraded Arlo Technologies Inc ARLO from Neutral to Buy. Arlo Technologies shares rose 3.73 percent to $19.75 in pre-market trading.
- William Blair upgraded Tilly's Inc TLYS from Market Perform to Outperform. Tilly's shares rose 15.56 percent to $20.80 in pre-market trading.
- JP Morgan upgraded Nutanix Inc NTNX from Underweight to Neutral. Nutanix shares gained 1.1 percent to $61.80 in pre-market trading.
- Bank of America upgraded Shinhan Financial Group Co., Ltd. (ADR) SHG from Neutral to Buy. Shinhan Financial shares closed at $38.90 on Wednesday.
- Pivotal Research upgraded Genesco Inc. GCO from Hold to Buy. Genesco shares rose 1.87 percent to close at $46.35 on Wednesday.
- KeyBanc upgraded Altra Industrial Motion Corp AIMC from Sector Weight to Overweight. Altra Industrial Motion shares fell 0.13 percent to close at $38.00 on Wednesday.
- Analysts at Citigroup upgraded Itau Corpbanca (ADR) ITCB from Neutral to Buy. Itau Corpbanca shares fell 2.65 percent to $14.31 in pre-market trading.
- Bank of America downgraded Vodafone Group Plc (ADR) VOD from Buy to Neutral. Vodafone shares fell 3 percent to $22.29 in pre-market trading.
- SunTrust Robinson Humphrey downgraded RPC, Inc. RES from Buy to Hold. RPC shares rose 0.08 percent to $14.40 in pre-market trading.
- Bank of America downgraded KB Financial Group, Inc. (ADR) KB from Buy to Neutral. KB Financial shares rose 0.26 percent to close at $47.17 on Wednesday.
- Sandler O'Neill downgraded Hanover Insurance Group Inc THG from Buy to Neutral. Hanover Insurance shares fell 1.16 percent to close at $126.54 on Wednesday.
- Bank of America downgraded Grupo Supervielle SA -ADR SUPV from Buy to Neutral. Grupo Supervielle shares fell 0.71 percent to $5.61 in pre-market trading.
- Berenberg initiated coverage on Tandem Diabetes Care Inc TNDM with a Buy rating. The price target for Tandem Diabetes Care is set to $50. Tandem Diabetes Care shares closed at $40.93 on Wednesday.
- Chardan Capital initiated coverage on Tocagen Inc TOCA with a Buy rating. The price target for Tocagen is set to $30. Tocagen shares closed at $8.39 on Wednesday.
- Analysts at SunTrust Robinson Humphrey initiated coverage on Adverum Biotechnologies Inc ADVM with a Buy rating. The price target for Adverum Biotechnologies is set to $11. Adverum Biotechnologies shares closed at $6.12 on Wednesday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.